Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations
Journal of Cystic Fibrosis · 2024-07 · 23 (4) · 603-611
DOI: 10.1016/j.jcf.2024.04.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cystic Fibrosis, 2024-07. Verfasst von Jonathan D Cogen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA. …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Disease Progression. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, Gilead Sciences.
Abstract (Originalsprache)
Pulmonary exacerbations in people with cystic fibrosis are associated with significant morbidity and reduced quality of life. Pulmonary exacerbation treatment guidelines, published by an expert panel assembled by the Cystic Fibrosis Foundation nearly 15 years ago, were primarily consensus-based as there were several gaps in the evidence base. In particular, limited evidence existed regarding optimal pulmonary exacerbation treatment strategies, including duration of antibiotic therapy, treatment location, antibiotic selection, and the role of systemic corticosteroids. Over the last decade, results from observational studies and large multi-center randomized controlled trials have begun to answer important questions related to pulmonary exacerbation treatment. This review focuses on the diagnosis, etiology, and changing epidemiology of pulmonary exacerbations, and also summarizes the most recent and up-to-date studies describing pulmonary exacerbation treatment. Finally, this review provides consideration for future pulmonary exacerbation research priorities, particularly in the current highly effective modulator therapy era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA. Electronic address: jonathan.cogen@seattlechildrens.org.
- Division of Respiratory Medicine, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Förderung
- Cystic Fibrosis Foundation
- Gilead Sciences
Zitieren
APA
Cogen, J. D., & Quon, B. S. (2024). Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations. Journal of Cystic Fibrosis, 23(4), 603-611. https://doi.org/10.1016/j.jcf.2024.04.004
Vancouver
Cogen JD, Quon BS. Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations. Journal of Cystic Fibrosis. 2024;23(4):603-611. doi:10.1016/j.jcf.2024.04.004
BibTeX
@article{Cogen2024,
author = {Cogen, Jonathan D and Quon, Bradley S},
title = {Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations},
journal = {Journal of Cystic Fibrosis},
year = {2024},
volume = {23},
number = {4},
pages = {603--611},
doi = {10.1016/j.jcf.2024.04.004}
}
EUVIMED